Freenome (FRNM) via Perceptive Capital Solutions (PCSC) deck
Freenome develops multiomic, blood-based early cancer detection tests that use AI to identify cancer at its earliest and most treatable stages.
Freenome develops multiomic, blood-based early cancer detection tests that use AI to identify cancer at its earliest and most treatable stages.
%20via%20Perceptive%20Capital%20Solutions%20(PCSC)%20deck){kind=link}